•FDA clears Bausch + Lomb's Bi-Blade+ vitrectomy cutter and fluidics technology•Study links poor diet with increased pediatric myopia•FDA clears the OCULUS Pentacam Cornea OCT•i-Lumen Scientific earns FDA IDE clearance for dry AMD trial•TEPEZZA on-body injector demonstrates positive phase 3 performance for TED•FDA clears Bausch + Lomb's Bi-Blade+ vitrectomy cutter and fluidics technology•Study links poor diet with increased pediatric myopia•FDA clears the OCULUS Pentacam Cornea OCT•i-Lumen Scientific earns FDA IDE clearance for dry AMD trial•TEPEZZA on-body injector demonstrates positive phase 3 performance for TED
HEADLINES
FEATURED
Updated labeling enables IVT treatment beyond 6 months, intended to enable more flexible and tailored treatment plans.
Earn FREE CE 24/7 with Courses by Eyes On Eyecare
Explore premium-quality, bite-sized courses featuring leading experts like Cecelia Koetting, OD, FAAO, and Cory Lappin, OD, MS, FAAO, and continuing education covering topics from ocular rosacea treatments to retinal disease.
